propylthiouracil (redirected from Propyl-Thyracil)

propylthiouracil /pro·pyl·thio·ura·cil/ (pro″pil-thi″o-u´rah-sil) a thyroid inhibitor used in the treatment of hyperthyroidism.

---

pro·pyl·thi·o·u·ra·cil (prpl-th-yr-sl)

n.

Abbr. PTU An agent that inhibits the synthesis of thyroid hormones and is used in the treatment of hyperthyroidism.

---

propylthiouracil

[prō′pilthī′əyoo͡r′əsil]

an inhibitor of thyroid hormone biosynthesis.

indications It is prescribed in treatment of hyperthyroidism and thyrotoxic crisis and in preparation for thyroidectomy.

contraindications Mental depression, cold intolerance, or known hypersensitivity to this drug prohibits its use. Caution is recommended in pregnancy, in patients older than 40 years of age (can cause hypoprothrombinemia and bleeding), and in use in combination with other drugs that can cause agranulocytosis.

adverse effects Among the more serious adverse effects are GI distress, pruritus, and rashes. Rarely blood dyscrasia occurs.

---

propylthiouracil (PTU), (prō´plthī´ōyr´sil),

n brand name: generic;
drug class: thyroid hormone antagonist;
action: blocks synthesis of thyroid hormones T₃ (triiodothyronine) and T₄ (thyroxine);
uses: preparation for thyroidectomy, thyrotoxic crisis, hyperthyroidism, thyroid storm.

---

propylthiouracil

a thyroid inhibitor used in the treatment of hyperthyroidism, but because of severe hematologic toxicity in cats other drugs are preferred.

---

propylthiouracil (PTU)

Propyl-Thyracil (CA)

Pharmacologic class: Thioamide derivative

Therapeutic class: Antithyroid agent

Pregnancy risk category D

Action

Directly interferes with thyroid synthesis by preventing iodine from combining with thyroglobulin, leading to decreased thyroid hormone levels

Availability

Tablets: 50 mg

⊘Indications and dosages

➣ Hyperthyroidism

Adults: Initially, 300 to 450 mg P.O. daily in equally divided doses q 8 hours; for maintenance, 100 to 150 mg P.O. daily.

➣ Thyrotoxic crisis

Adults: 200 mg P.O. q 4 to 6 hours during first 24 hours, then a maintenance dosage of 100 to 150 mg P.O. daily

Contraindications

• Hypersensitivity to drug
• Pregnancy and breastfeeding

Precautions

Use cautiously in:
• decreased bone marrow reserve.

Administration

• Give with meals to reduce GI upset.

Route	Onset	Peak	Duration
P.O.	Unknown	1-1.5 hr	Unknown

Adverse reactions

CNS: drowsiness, headache, vertigo, neuritis, paresthesia

GI: nausea, vomiting, diarrhea, epigastric distress

Hematologic: agranulocytosis, leukopenia, thrombocytopenia

Hepatic: jaundice, hepatic necrosis

Metabolic: hypothyroidism

Musculoskeletal: joint pain, myalgia

Skin: rash, urticaria, pruritus, skin discoloration, alopecia, cutaneous vasculitis

Other: taste loss, fever, lymphadenopathy, parotitis, edema

Interactions

Drug-drug. Anticoagulants: potentiation of anticoagulant effect

Drug-diagnostic tests. Alanine aminotransferase, alkaline phosphatase, aspartate aminotransferase, bilirubin, lactate dehydrogenase: increased levels

Granulocytes, platelets: decreased levels

Prothrombin time: prolonged

Patient monitoring

• Monitor CBC and liver and thyroid function tests.
• Assess for signs and symptoms of hypothyroidism (cold intolerance, nonpitting edema, fatigue, weight gain, and depression).
☞ Monitor for severe rash, fever, or enlarged cervical lymph nodes. If present, stop therapy and notify prescriber.

Patient teaching

• Instruct patient to take with meals to reduce GI upset.
• Teach patient to recognize and report signs and symptoms of hypothyroidism and jaundice.
• Advise patient to discuss iodine intake (as in iodized salt and shellfish) with prescriber.
• Tell patient to avoid over-the-counter cold remedies that contain iodine.
• Caution patient to avoid driving and other hazardous activities until he knows how drug affects concentration and alertness.
• Advise female patient of childbearing age to discuss pregnancy or breastfeeding with prescriber before taking.
• As appropriate, review all other significant and life-threatening adverse reactions and interactions, especially those related to the drugs and tests mentioned above.